Healthcare Triangle, Inc. (HCTI) is a Technology stock trading at $0.94 (as of 2026-08-20), with a market capitalization of $1.85M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Healthcare Triangle, Inc. develops healthcare IT solutions spanning cloud services, data science, and professional and managed services for healthcare and life sciences organizations. Its platforms include CloudEz for managing multi-cloud infrastructure, DataEz for analytics and data science, and Readabl.AI, which uses public cloud AI/ML to extract healthcare information from documents.
Healthcare Triangle develops healthcare-focused cloud and data science software platforms, plus professional and managed services, that help healthcare and pharma organizations deliver personalized healthcare and precision medicine.
Its profit engine is tied to delivering healthcare and pharma software platforms (cloud and data science) together with professional and managed services that support digital transformation, drug discovery, and precision medicine use cases.
Business quality (Weak): The core business focus is clear, but the provided facts do not include reportable segments or investor-style operating KPIs, which limits visibility into what drives performance.
| Price | $0.94 |
| Market Cap | $1.85M |
| Price / Book | 0.04 |
| Price / Sales | 0.07 |
| FCF Yield | -452.6% |
| Revenue (TTM) | $13.89M |
| Net Margin | -68.2% |
| Revenue Growth (YoY) | 158.4% |
| EPS Growth (YoY) | 169.0% |
| Altman Z-Score | -3.35 (distress) |
| Piotroski F-Score | 4/9 (moderate) |
| Sector P/E (Technology) | 33.9 |
| Industry P/E (Computers) | 32.1 |
| Top Institutional Holder | UBS Group AG ($109524.00) |
| Institutional Holders Tracked | 10 |
| Sector | Technology |
| Industry | Computers |
| CEO | Lakshmanan Kannappan |
| Employees | 36 |
| Country | US |
| IPO Date | 2021-10-13 |
Data as of 2026-08-20.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.